Insider Transactions in Q4 2020 at Silk Road Medical Inc (SILK)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+5.46%
|
$54,000
$3.17 P/Share
|
|
Dec 29
2020
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-6.39%
|
$600,000
$60.04 P/Share
|
|
Dec 14
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.56%
|
$7,000
$1.6 P/Share
|
|
Dec 11
2020
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-4.63%
|
$638,000
$58.35 P/Share
|
|
Dec 11
2020
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+4.37%
|
$11,000
$1.53 P/Share
|
|
Dec 11
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.77%
|
$7,000
$1.6 P/Share
|
|
Dec 01
2020
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,472
-27.4%
|
$418,432
$56.63 P/Share
|
|
Dec 01
2020
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,472
+21.5%
|
$7,472
$1.46 P/Share
|
|
Nov 25
2020
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
10,000
-7.02%
|
$570,000
$57.08 P/Share
|
|
Nov 25
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.56%
|
$40,000
$4.73 P/Share
|
|
Nov 23
2020
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Exercise of conversion of derivative security
|
Direct |
108,974
+29.69%
|
$108,974
$1.55 P/Share
|
|
Nov 20
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
83
+0.06%
|
$2,739
$33.06 P/Share
|
|
Nov 17
2020
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
SELL
Open market or private sale
|
Direct |
14,221
-27.07%
|
$839,039
$59.84 P/Share
|
|
Nov 17
2020
|
Richard Ruedy EVPClin&Reg.Affairs&QA |
BUY
Exercise of conversion of derivative security
|
Direct |
14,221
+21.3%
|
$14,221
$1.42 P/Share
|
|
Nov 11
2020
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
11,000
-8.97%
|
$693,000
$63.44 P/Share
|
|
Nov 11
2020
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+8.23%
|
$11,000
$1.46 P/Share
|
|
Nov 06
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
21,496
+13.96%
|
-
|
|
Nov 02
2020
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,640
-25.11%
|
$405,040
$61.37 P/Share
|
|
Nov 02
2020
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,640
+20.07%
|
$6,640
$1.46 P/Share
|
|
Oct 14
2020
|
Lucas W. Buchanan COO & CFO |
SELL
Open market or private sale
|
Direct |
9,600
-4.11%
|
$624,000
$65.21 P/Share
|
|
Oct 14
2020
|
Lucas W. Buchanan COO & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,600
+3.92%
|
$38,400
$4.73 P/Share
|
|
Oct 12
2020
|
Erica J. Rogers President and CEO |
SELL
Open market or private sale
|
Direct |
20,044
-15.23%
|
$1,322,904
$66.16 P/Share
|
|
Oct 12
2020
|
Erica J. Rogers President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,044
+13.21%
|
$20,044
$1.46 P/Share
|
|
Oct 01
2020
|
Andrew S. Davis Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,635
-25.1%
|
$431,275
$65.6 P/Share
|
|
Oct 01
2020
|
Andrew S. Davis Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,635
+20.06%
|
$6,635
$1.46 P/Share
|